Skip to main content

Health Catalyst, Inc. (HCAT) Stock Forecast 2025 - AI Price Prediction & Analysis


Health Catalyst, Inc. (HCAT) AI Stock Price Forecast & Investment Analysis

Health Catalyst, Inc. Stock Price Chart and Technical Analysis

Loading Health Catalyst, Inc. interactive price chart and technical analysis...

Health Catalyst, Inc. (HCAT) - Comprehensive Stock Analysis & Investment Research

Deep dive into Health Catalyst, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Health Catalyst, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Health Catalyst, Inc.: Health Catalyst, Inc. operates in the Technology sector, making it an emerging small-cap investment.

Health Catalyst, Inc. (Stock Symbol: HCAT) is a leading company in the Technology sector , specifically operating within the Services-Computer Programming, Data Processing, Etc. industry.

The organization employs approximately 1313 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Health Catalyst, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Health Catalyst, Inc.: With $316M in annual revenue and -23.8% net margin, the company demonstrates developing profitability.

Annual Revenue: $316 million generating a -23.8% net profit margin .

Market Capitalization: $238 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -39.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Health Catalyst, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Health Catalyst, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Health Catalyst, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Health Catalyst, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Health Catalyst, Inc.: Market positioning analysis based on available financial and operational metrics.

Health Catalyst, Inc. strategically competes in the highly dynamic Services-Computer Programming, Data Processing, Etc. marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 37.0% gross margin, indicating strong pricing power and operational efficiency.

Health Catalyst, Inc. (HCAT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Health Catalyst, Inc. stock analysis.

Loading Health Catalyst, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Health Catalyst, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Health Catalyst, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Health Catalyst, Inc.: With a P/E ratio of -5.91, the market sees the stock as potentially undervalued.

P/E Ratio -5.91x
P/B Ratio 0.68x
Market Cap $238M
EPS $-1.51
Book Value/Share $4.95
Revenue/Share $4.50
FCF/Share $-1.03
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Health Catalyst, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Health Catalyst, Inc.: An ROE of -39.3% indicates room for improvement in shareholder value creation.

ROE -39.3%
ROA -21.1%
ROIC -22.4%
Gross Margin 37.0%
Operating Margin -26.4%
Net Margin -23.8%
EBT Margin -62.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Health Catalyst, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Health Catalyst, Inc.: A current ratio of 5.21 indicates strong liquidity.

Current Ratio 5.21x
Quick Ratio 5.05x
D/E Ratio 0.51x
Financial Leverage 1.72x
Interest Coverage -9.5x
Working Capital $242M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Health Catalyst, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Health Catalyst, Inc.: Free cash flow of $-34M indicates cash challenges that need attention.

Operating Cash Flow $-19M
Free Cash Flow $-34M
Capital Spending $-15M
FCF/Sales -13.4%
CapEx/Sales 6.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Health Catalyst, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Health Catalyst, Inc.: An asset turnover of 0.36x suggests room for improvement in asset utilization.

Asset Turnover 0.36x
Receivables Turnover 5.7x
Fixed Assets Turnover 5.8x
Days Sales Outstanding 64 days
Payables Period 15 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Health Catalyst, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Health Catalyst, Inc.: With annual revenue of $316M, Health Catalyst, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $316M
R&D Expense $63M
SG&A Expense $63M
Cost of Goods Sold $165M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 58%
Cash & Short-term Investments 52%
Total Liabilities 42%
Short-term Debt 21%
Accounts Receivable 5%
Dividend & Shareholder Information
Shares Outstanding 70M
Growth Metrics (YoY)
EPS Growth -24.7%

Latest Health Catalyst, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Health Catalyst, Inc. (HCAT) stock price and investment outlook.

📰 We are currently updating our news feed for Health Catalyst, Inc.. Check back soon for the latest market analysis and company updates.

Health Catalyst, Inc. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Health Catalyst, Inc. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
APP Unlock Forecast - 30 Days FREE Trial $194822M 80.2x 166.9x
BAIDF Unlock Forecast - 30 Days FREE Trial $437M x 0.3x
BBLR Unlock Forecast - 30 Days FREE Trial $2M x x
BIDU Unlock Forecast - 30 Days FREE Trial $3757M x 3.0x
BLND Unlock Forecast - 30 Days FREE Trial $-6077M -11.7x -26.7x
BMBL Unlock Forecast - 30 Days FREE Trial $1190M -5.7x 2.1x
BRGX Unlock Forecast - 30 Days FREE Trial $10M x x
BZ Unlock Forecast - 30 Days FREE Trial $22244M x 1.8x
CCTC Unlock Forecast - 30 Days FREE Trial $0M x x
CDLX Unlock Forecast - 30 Days FREE Trial $88M -1.4x 1.4x
CEVA Unlock Forecast - 30 Days FREE Trial $542M -115.7x 2.0x
CNET Unlock Forecast - 30 Days FREE Trial $4M -14.8x 0.8x
CNNN Unlock Forecast - 30 Days FREE Trial $1M x x
CSAI Unlock Forecast - 30 Days FREE Trial $21M x 2.6x
DJT Unlock Forecast - 30 Days FREE Trial $4119M x 4.6x
DJTWW Unlock Forecast - 30 Days FREE Trial $4547M x 5.1x
DOCN Unlock Forecast - 30 Days FREE Trial $3471M 27.5x -12.8x
DSP Unlock Forecast - 30 Days FREE Trial $1554M 660.0x 56.6x
DV Unlock Forecast - 30 Days FREE Trial $2323M 44.1x 2.1x
EB Unlock Forecast - 30 Days FREE Trial $254M -27.3x 1.4x
EVER Unlock Forecast - 30 Days FREE Trial $0M -36.7x 0.0x
FDS Unlock Forecast - 30 Days FREE Trial $13912M 26.1x 6.5x
FLUT Unlock Forecast - 30 Days FREE Trial $M x x
GAN Unlock Forecast - 30 Days FREE Trial $92M -4.3x -5.6x
GDS Unlock Forecast - 30 Days FREE Trial $31533M x 7.1x
GITS Unlock Forecast - 30 Days FREE Trial $7M x 1.2x
GOOG Unlock Forecast - 30 Days FREE Trial $2879657M 24.9x 7.9x
GOOGL Unlock Forecast - 30 Days FREE Trial $2928637M 25.3x 8.1x
GRND Unlock Forecast - 30 Days FREE Trial $3987M -48.5x -56.5x
HCAT Unlock Forecast - 30 Days FREE Trial $238M -5.9x 0.7x
HOLO Unlock Forecast - 30 Days FREE Trial $24M x 0.1x
HOLOW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
HSTM Unlock Forecast - 30 Days FREE Trial $864M 42.5x 2.5x
IAC Unlock Forecast - 30 Days FREE Trial $2966M -14.7x 0.6x
IAS Unlock Forecast - 30 Days FREE Trial $1365M 188.8x 1.3x
IPDN Unlock Forecast - 30 Days FREE Trial $12M -1.2x 2.7x
IPM Unlock Forecast - 30 Days FREE Trial $25M x 1.2x
KIND Unlock Forecast - 30 Days FREE Trial $0M -7.4x 0.0x
LGCL Unlock Forecast - 30 Days FREE Trial $36M x 0.1x
META Unlock Forecast - 30 Days FREE Trial $1940108M 27.1x 10.0x
MGNI Unlock Forecast - 30 Days FREE Trial $3463M -328.6x 4.7x
MITI Unlock Forecast - 30 Days FREE Trial $2M 1.5x x
MRKY Unlock Forecast - 30 Days FREE Trial $1M x x
MTCH Unlock Forecast - 30 Days FREE Trial $8067M 14.2x -44.2x
NBIS Unlock Forecast - 30 Days FREE Trial $34603M x 24.1x
NIQ Unlock Forecast - 30 Days FREE Trial $0M 4.2x 0.0x
OB Unlock Forecast - 30 Days FREE Trial $234M -28.7x 0.5x
OBLG Unlock Forecast - 30 Days FREE Trial $4M -5.8x 0.4x
PALT Unlock Forecast - 30 Days FREE Trial $18M -8.0x 1.1x
PINS Unlock Forecast - 30 Days FREE Trial $24336M 12.6x 5.1x
PODC Unlock Forecast - 30 Days FREE Trial $40M -58.5x 2.7x
PUBM Unlock Forecast - 30 Days FREE Trial $400M 96.6x 1.6x
QSJC Unlock Forecast - 30 Days FREE Trial $2M x x
RUM Unlock Forecast - 30 Days FREE Trial $0M -13.0x 0.0x
RUMBW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
RXT Unlock Forecast - 30 Days FREE Trial $335M -0.7x -0.3x
SABR Unlock Forecast - 30 Days FREE Trial $675M -3.8x -0.9x
SMWB Unlock Forecast - 30 Days FREE Trial $815M x 29.6x
SNAP Unlock Forecast - 30 Days FREE Trial $20639M -18.1x 9.3x
SOGP Unlock Forecast - 30 Days FREE Trial $20667M x 797.1x
SST Unlock Forecast - 30 Days FREE Trial $54M -0.4x 0.9x
TBLA Unlock Forecast - 30 Days FREE Trial $1328M -29.1x 1.3x
TBLAW Unlock Forecast - 30 Days FREE Trial $120M x 0.1x
TEAD Unlock Forecast - 30 Days FREE Trial $251M x 0.5x
TEM Unlock Forecast - 30 Days FREE Trial $13M x 0.0x
TRIP Unlock Forecast - 30 Days FREE Trial $2448M 37.7x 3.9x
TRUE Unlock Forecast - 30 Days FREE Trial $191M -6.5x 1.8x
TTD Unlock Forecast - 30 Days FREE Trial $23040M 55.2x 8.6x
VMEO Unlock Forecast - 30 Days FREE Trial $780M 59.2x 2.0x
VNET Unlock Forecast - 30 Days FREE Trial $6631M x 9.0x
WB Unlock Forecast - 30 Days FREE Trial $2925M x 0.9x
WEIBF Unlock Forecast - 30 Days FREE Trial $2430M x 0.8x
WIX Unlock Forecast - 30 Days FREE Trial $9835M x x
YYAI Unlock Forecast - 30 Days FREE Trial $18M -1.8x 2.0x
ZIP Unlock Forecast - 30 Days FREE Trial $481M 38.9x 0.0x
ZM Unlock Forecast - 30 Days FREE Trial $26012M 21.9x 2.9x

Frequently Asked Questions - Health Catalyst, Inc. Stock Forecast

How accurate are Health Catalyst, Inc. stock predictions?

Our AI model demonstrates 62% historical accuracy for HCAT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Health Catalyst, Inc. stock price forecasts?

Our analysis considers Health Catalyst, Inc.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Health Catalyst, Inc. a good investment in 2025?

Based on our AI analysis, Health Catalyst, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Health Catalyst, Inc. forecasts updated?

Health Catalyst, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Health Catalyst, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Health Catalyst, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...